<DOC>
	<DOCNO>NCT01117090</DOCNO>
	<brief_summary>The purpose study record signatures fluid surround spinal cord people implanted drug infusion system .</brief_summary>
	<brief_title>Measuring Signatures Fluid Surrounding Spinal Cord Patients Who Have Problems With Intrathecal Drug Delivery</brief_title>
	<detailed_description>The purpose feasibility study record cerebrospinal fluid ( CSF ) signatures subject implant drug infusion system undergo clinical test design troubleshoot possible catheter-related problem part normal standard care . Signatures correlate physician-determined catheter status .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<criteria>Be least 12 year age Have implant Medtronic drug infusion system chronic intrathecal administration drug Report decrease therapeutic benefit , show visible sign and/or symptom decrease therapeutic benefit Agree undergo clinical test design troubleshoot catheterrelated problem failure part normal standard care Agree provide sign informed consent . Are currently enrol plan enroll another investigational drug device trial Have participate investigational drug device study within 30 day inclinic visit Whose health status would , opinion Clinical Investigator , jeopardize participation study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Feasibility</keyword>
	<keyword>SynchroMed II</keyword>
	<keyword>Intrathecal catheter</keyword>
	<keyword>Baclofen</keyword>
</DOC>